Pyxis Oncology, Inc. (PYXS) Tops Q2 EPS by 4c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Evolution Petroleum to buy Midland Basin mineral rights for $16M
• Sk Hynix Union Is Finalising Wording Of Tentative Wage Deal, And Will Brief Its Members On The Terms This Afternoon- Reuters